SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Mariam Maghribi of Atia Vision and Shifamed, delivers updates from each company including developments for the OmniVu IOL system.
“We have demonstrated the full range of functional vision for patients with minimal visual disturbances and are building up to get into the U.S. [investigational device exemption] study hopefully next year,” she said.
Maghribi also previewed an upcoming titratable therapy for the treatment of moderate to severe glaucoma.